Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Zynga Inc (NASDAQ:ZNGA), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), Atmel Corporation (NASDAQ:ATML).
Zynga Inc (NASDAQ:ZNGA) ended its recent business day with the tumbled of -1.95% and closed at the price of $4.03 after opening at $4.09. The stock traded during its last trading session with the total volume of 14.09 million shares, as compared to its average volume of 16.37 million shares. Zynga Inc. develops, markets, and operates online social games as live services on the Internet, social networking sites, and mobile platforms in the United States and internationally.
Has ZNGA Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) remained among the day bullish 3.92% and traded with volume of 11.88 million shares in the last session, as compared to average volume of 4.14 million shares. In comparison with 52 week range of $4.05 - $11.00, it faced lowest price of $6.50 during the last trading session whereas its day highest price was $6.92. The company’s total market capitalization is $1.45 billion, along with 218.57 million shares outstanding. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Will ARNA Continue To Move Higher? Find out via this report
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) showed 7.95 million shares in volume during the last trading session, while the average trading volume remained 1.54 million shares. The stock kicked off its trading session at $7.61 and closed at $6.70 after dropped -8.84%. Oxygen Biotherapeutics, Inc., a development stage company, engages in developing biotechnology products that deliver oxygen to target tissues in the body primarily in the United States.
Will OXBT Get Buyers Even After The Recent Rally? Find Out Here
Atmel Corporation (NASDAQ:ATML) stock traded during its last trading session with the total traded volume of 13.71 million shares versus its average volume of 5.68 million shares. The company opened its trade at the price of $8.66 and its closing price was $8.63 after fell -1.71% for the day. Atmel Corporation designs, develops, manufactures, and sells semiconductor integrated circuit (IC) products.
Has ATML Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)